8QQ
vs
D
DAX Index
8QQ
Over the past 12 months, 8QQ has underperformed DAX Index, delivering a return of -16% compared to the DAX Index's +9% growth.
Stocks Performance
8QQ vs DAX Index
Performance Gap
8QQ vs DAX Index
Performance By Year
8QQ vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Abcellera Biologics Inc
Glance View
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 386 full-time employees. The company went IPO on 2020-12-11. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.